RxDoctor Payments Data

Deepika Singh

Pediatric Rheumatology · Madera, CANPI 1275844946

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 117 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Amgen at 36.0% of the total. Reporting peaked in 2019 at $925 and has fallen 88.8% since, to $104 in 2025.

$2,410in general payments, 2019–2025

Across 117 payments — averaging $20.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$867
  • Novartis$246
  • Pfizer$226
  • AbbVie$188
  • Genentech USA, Inc.$171
  • GSK$167
  • plus $545 from 10 others

What the payments were for

  • Food & beverage$2,410100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,410 in reported general payments places this provider in the 65th percentile of 39 pediatric rheumatology providers in California.

See all pediatric rheumatology providers in California

Other pediatric rheumatology in Madera

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →